Tag: Indian

Researchers at IIT Kharagpur have developed devices for automating a range of functions for planting sugarcane buds, fitted with an autonomous fungicide application......................

Under the strategic alliance, Indian Council for Medical Research is providing continuous support to Serum Institute of India in conducting and funding the ongoing clinical trials of COVISHIELD across 15 centres in India....................

Indian National Science Academy has honored Chairman, and Chief Diabetologist of Dr Mohan’s Diabetes Specialities Centre and President and Director of Madras Diabetes Research Foundation, Chennai, Dr V.Mohan with the prestigious Prof.K.P.Bhargava Memorial Medal 2020.................

ICAR has been recognizing and rewarding the institutions, scientists, teachers, farmers and agricultural journalists every year. This year; nearly 160 awardees under 20 different categories have been selected..................

The company in collaboration with Griffith University, Australia will commence the research and later file for vaccine approvals with the Indian regulator post the preliminary research.........................

As per Mr Rajiv Nath, Forum Coordinator of Association of Indian Medical Device Industry (AiMeD), the budget is a visionary and well thought out one tailored for promoting Make in India of medical devices and addressing Indian National Healthcare security concerns..................

The conference will be focused on ‘Beyond New Regulations- Increasing Participation and Enhancing Patient Safety’. While Dr V G Somani, Drug Controller General India, CDSCO, to be the Chief Guest, Dr Gagandeep Kang, Executive Director, THSTI will deliver late Prof Ranjit Roy Chaudhury Oration........................

Inaugurating the 107th session of the Indian Science Congress, which began at Bengaluru on 3rd January, the Prime Minister, Narendra Modi noted that technology and good effective governance had been behind the success of major welfare programmes from Swachcha Bharat Abhiyan to Ayushman Bharat....................

Domestic pharma cos expected to grow at a CAGR of around 10-12% between FY2019-2022. The productivity of R&D expenditure, operational risk related to an increased level of due diligence by regulatory agencies and price controls are key concerns................

The union health ministry has asked the Indian Council for Medical Research to investigate the clinical trials conducted by Nestle India Limited on the pre-term babies at various hospitals in India